Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions
Clinical Science · 2024
DOI: 10.1042/cs20240328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Mia Edgerton-Fulton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A. Hauptthemen laut MEDLINE: Brain, Cellular Senescence, Endothelin-1, Pericytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Veterans Affairs (VA) Merit Review, BLRD VA, NINDS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mediates endothelial dysfunction and increases the risk of Alzheimer’s disease and related dementias. Diabetes also dysregulates the ET system. ET-1-mediated constriction of brain microvascular pericytes (BMVPCs) has been shown to contribute to brain hypoperfusion. Cellular senescence, a process that arrests the proliferation of harmful cells and instigates phenotypical changes and proinflammatory responses in endothelial cells that impact their survival and function. Thus, we hypothesized that ET-1 mediates BMVPC senescence and phenotypical changes in diabetes-like conditions. Human BMVPCs were incubated in diabetes-like conditions with or without ET-1 (1 µmol/L) for 3 and 7 days. Hydrogen peroxide (100 µmol/L H2O2) was used as a positive control for senescence and to mimic ischemic conditions. Cells were stained for senescence-associated β-galactosidase or processed for immunoblotting and quantitative real-time PCR analyses. In additional experiments, cells were stimulated with ET-1 in the presence or absence of ETA receptor antagonist BQ-123 (20 μmol/L) or ETB receptor antagonist BQ-788 (20 μmol/L). ET-1 stimulation increased β-galactosidase accumulation which was prevented by BQ-123. ET-1 also increased traditional senescence marker p16 protein and pericyte-specific senescence markers, TGFB1i1, PP1CA, and IGFBP7. Furthermore, ET-1 stimulated contractile protein α-SMA and microglial marker ostepontin in high glucose suggesting a shift toward an ensheathing or microglia-like phenotype. In conclusion, ET-1 triggers senescence, alters ETA and ETB receptors, and causes phenotypical changes in BMVPCs under diabetes-like conditions. These in vitro findings need to be further studied in vivo to establish the role of ETA receptors in the progression of pericyte senescence and phenotypical changes in VCID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, U.S.A.
- Ralph H Johnson VA Health Care System, Medical University of South Carolina, Charleston, SC, U.S.A.
ORCID-Profile: Mia Edgerton-Fulton
Förderung
- Veterans Affairs (VA) Merit Review
- BLRD VA
- NINDS NIH HHS
- NINDS-Diversity Supplement
- VA Senior Research Career Scientist Award
- National Institute of Health
Zitieren
APA
Edgerton-Fulton, M., Abdul, Y., Jamil, S., & Ergul, A. (2024). Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions. Clinical Science. https://doi.org/10.1042/cs20240328
Vancouver
Edgerton-Fulton M, Abdul Y, Jamil S, Ergul A. Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions. Clinical Science. 2024. doi:10.1042/cs20240328
BibTeX
@article{EdgertonFulton2024,
author = {Edgerton-Fulton, Mia and Abdul, Yasir and Jamil, Sarah and Ergul, Adviye},
title = {Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions},
journal = {Clinical Science},
year = {2024},
doi = {10.1042/cs20240328}
}
EUVIMED